First Gastrointestinal

Please consult complete prescribe data, accessible at or by calling Robin Gaitens at GlaxoSmithKline (USA) at (919) 483-2839.

AMITIZA should not be administered to patients that hold stringent diarrhea. Patients should be cognisant of the latent rate of diarrhea during apt. If the diarrhea or nausea become severe, patients should consult their energy executive.

In clinical torment in support of Chronic Idiopathic Constipation (24 mcg two times daily), the furthermost established adverse answer be nausea (29%). Other adverse reaction (greater than or indistinguishable to 5% of patients) integrated diarrhea (12%), headache (11%), abdominal persecute (8%), abdominal distension (6%) and flatulence (6%).

For full uphill prescribe communication, type contained with AMITIZA(R) be a check trademark of Sucampo Pharmaceuticals, Inc.

Sucampo Pharmaceuticals, Inc.

Sucampo Pharmaceuticals, Inc., is an emerging pharmaceutical camaraderie holder in Bethesda, Md. Sucampo Pharmaceuticals was found in 1996 by Ryuji Ueno, M.D., Ph.D., Ph.D., the company’s Chairman and Chief Executive Officer, and co-founder, Sachiko Kuno, Ph.D. Sucampo Pharmaceuticals focus at the side of the ladder frontal and commercialization of drugs based on prostones, a tutorial of complex derived from functional fatty acids that come to pass readily in the human article. The beneficial eventual of prostones was opening identified by Dr. Ueno. In January 2006, Sucampo Pharmaceuticals received marketing sanction from the U.S. Food and Drug Administration for its first provision, AMITIZA, for the treatment of Chronic Idiopathic Constipation in adults. In October 2004, Sucampo Pharmaceuticals enter into an agreement with Takeda Pharmaceutical Company Limited (Osaka, Japan) to co-promote and souk AMITIZA in the United States and Canada.

Sucampo Pharmaceuticals’ specialized mart harass complement the productiveness of Takeda by focus on institutional and long- occupancy neatness services. To cram more more or less the company and its products, visit Takeda Pharmaceuticals North America, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc., is a fully relevant subsidiary of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. In the United States, Takeda in a minute market products for diabetes, impatience, wakefulness and gastroenterology. The company have a robust pipeline with compounds in development for diabetes, cardiovascular bug and other provisos. Takeda is committed to striving toward larger health for individuals and progress in medication by emergent first-rate pharmaceutical products. To learn more about the company and its products, visit Sucampo Pharmaceuticals; Takeda Pharmaceuticals North America

Now erectile dysfunction generic zocor here

Learn more about purchace generic tramadol

gastrointestinal blogs here